Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Bertoni
Genomic Profiles of MALT Lymphomas: Variability Across Anatomical Sites
Haematologica
Hematology
Discovering Dependencies, Trade‐offs, and Robustness in Joint Dam Design and Operation: An Ex‐post Assessment of the Kariba Dam
Earth's Future
Earth
Planetary Sciences
Environmental Science
The Transcription Factor Fli1 Sustains Relevant Biological Pathways and Drives Oncogenes That Promote Cell Growth in Diffuse Large B-Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Development of Novel Preclinical Models of Secondary Resistance to the Pi3kδ Inhibitor Idelalisib in Splenic Marginal Zone Lymphoma (Smzl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ets1 Positively Regulates Faim3 in Activated B Cell-Like (Abc) Diffuse Large B Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Sakk 35/15: A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Eg-011 Is a Novel Small Molecule With in Vitro and in Vivo Anti-Tumor Activity Against Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Copanlisib Synergies With Conventional and Targeted Agents Including Venetoclax in Preclinical Models of B- And T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ih2 Inhibition Enhances Proteasome Inhibitor Responsiveness in Hematological Malignancies
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combinatorial Screening of the Pi3k Inhibitor Copanlisib in T Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
1
2
›
